PARTNER SOLUTION PROFILE 

 logo

Remote Patient Monitoring for Pharma Clinical Trials

Wearable sensor solutions for continuous ECG and Vitals monitoring

 


 

Over 300,000 studies worldwide annually

Approximately 40% conducted in the US

 


 

Problem

Obtaining patient data in remote situations offers the potential to capture new insights and improve the efficiency of clinical trials. However, remote locations pose unique challenges when it comes to patient adherence, data collection, network connectivity, and data analysis.

Solution

  • AMPS continuous ECG recording suite (CER-S) combined with VivaLNK medical wearable sensors offer the best solution for providing real-time and retrospective analysis for continuous ECG datasets in remote environments.

  • The solution includes advanced algorithms designed to process large datasets for ECG analysis including atrial fibrillation, pauses, tachycardia, bradycardia.

     

Clipboard

Benefits

  • IoT enabled patient friendly medical wearables ensure adherence to protocols

  • Automatic data and network management offer reliable data transmission from remote locations

  • Continuously capture physiological data for a more comprehensive view of therapeutic safety and efficacy

  • Correlation of multiple parameters adds novel insights to traditional data analysis

  • Maintain data control and ownership; real-time or retrospective data collection

Clipboard01

 

Analyzed and Raw Data

  • Atrial Fibrillation

  • Ventricular Tachycardia

  • Supraventricular Tachycardia

  • Bradycardia

  • Pauses

  • ECG Trace

  • Heart Rate

  • RR-interval

  • Respiratory Rate

  • Temperature

  • 3-Axis Accelerometer

  • and more ...

 

 

About AMPS

AMPS is a world leader in quantitative ECG analysis. Working closely with pharmaceutical clients and CROs worldwide, it designs and provides ad-hoc state of the art technology, clinical expertise, and statistical support for quantitative ECG analysis. The company is a believer in innovation and continuously re-invests in R&D.